Baillie Gifford acquired 581 Thousand Edwards Lifesciences shares worth $42.8 Million. That's 0.03% of their equity portfolio (144th largest holding). The first Edwards Lifesciences trade was made in Q4 2018. Since then Baillie Gifford bought shares ten more times and sold shares on twelve occasions. The investor's estimated purchase price is $43.5 Million, resulting in a loss of 1.6%.